187 related articles for article (PubMed ID: 7059990)
1. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
Mazumder A; Grimm EA; Zhang HZ; Rosenberg SA
Cancer Res; 1982 Mar; 42(3):913-8. PubMed ID: 7059990
[TBL] [Abstract][Full Text] [Related]
2. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
[TBL] [Abstract][Full Text] [Related]
3. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
Strausser JL; Mazumder A; Grimm EA; Lotze MT; Rosenberg SA
J Immunol; 1981 Jul; 127(1):266-71. PubMed ID: 7195411
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
Mazumder A; Grimm EA; Rosenberg SA
J Immunol; 1983 Feb; 130(2):958-64. PubMed ID: 6848602
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
6. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
7. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
8. Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.
Mazumder A; Rosenstein M; Rosenberg SA
Cancer Res; 1983 Dec; 43(12 Pt 1):5729-34. PubMed ID: 6640524
[TBL] [Abstract][Full Text] [Related]
9. Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.
Mazumder A; Grimm EA; Rosenberg SA
Cancer Immunol Immunother; 1983; 15(1):1-10. PubMed ID: 6603260
[TBL] [Abstract][Full Text] [Related]
10. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
[TBL] [Abstract][Full Text] [Related]
12. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
Strauss G; Gückel B; Wallwiener D; Moldenhauer G
Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor associated macrophage-mediated lysis of autologous tumor cells by lectins.
Chattopadhyay U; Bhattacharyya S
Neoplasma; 1988; 35(3):321-8. PubMed ID: 3405340
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cytolytic T cell function by lectins.
Toribio ML; de la Hera A; Pereira P; de Landázuri MO
J Immunol; 1985 Apr; 134(4):2179-84. PubMed ID: 3871807
[TBL] [Abstract][Full Text] [Related]
15. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281
[TBL] [Abstract][Full Text] [Related]
16. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
[TBL] [Abstract][Full Text] [Related]
17. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
[TBL] [Abstract][Full Text] [Related]
18. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
19. Depressed lectin-dependent cell-mediated cytotoxicity against HEp-2 cells in patients with metastasizing solid tumour.
Perl A; Gonzalez-Cabello R; Láng I; Gergely P
Acta Physiol Hung; 1985; 65(2):149-53. PubMed ID: 3872553
[TBL] [Abstract][Full Text] [Related]
20. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]